GO:0043209 myelin sheath: Components, Assembly and Research

The myelin sheath (GO:0043209) is a specialized cellular component that ensheathes axons in the nervous system, providing electrical insulation and enabling rapid saltatory conduction of action potentials. It is produced by glial cells: Schwann cells myelinate peripheral neurons, while oligodendrocytes myelinate central nervous system axons. Beyond its insulating role, the myelin sheath is metabolically active and supports axonal integrity through trophic and metabolic coupling. The importance of myelin is underscored by its involvement in demyelinating diseases, nerve injury, and neurodegenerative conditions. Understanding the molecular composition and assembly of the myelin sheath is therefore a major research focus. Proteomic analyses have revealed a complex network of proteins, including myelin basic protein (MBP), proteolipid protein (PLP), and myelin-associated glycoprotein (MAG), that constitute the sheath and regulate its formation. Experimental models of peripheral nerve injury have been used to study myelin sheath degeneration and regeneration, providing insights into repair mechanisms. Recent advances in biomaterials and immunohydrogels aim to reconstruct the myelin sheath for peripheral nerve regeneration, highlighting translational applications. This article provides a comprehensive overview of the myelin sheath, its components, assembly, regulation, and the research methods used to study it, with a focus on CRISPR-based approaches for gene function analysis.

The myelin sheath (GO:0043209) is an electrically insulating fatty layer that surrounds the axons of many neurons. It is an outgrowth of glial cells: Schwann cells supply the myelin for peripheral neurons, while oligodendrocytes supply it to those of the central nervous system. This definition captures the essential structural and functional attributes of the myelin sheath as a cellular component.

The myelin sheath is critical for normal nervous system function because it enables rapid, efficient transmission of electrical signals along axons and provides essential metabolic support to maintain axonal integrity. Disruption of myelin sheath structure or composition leads to severe neurological deficits, as seen in demyelinating diseases and after nerve injury. Therefore, understanding the molecular mechanisms of myelin sheath formation, maintenance, and regeneration is of paramount importance for developing therapeutic strategies.

The following genes encode proteins that are major components of the myelin sheath or critical regulators of its formation and maintenance.

The formation and maintenance of the myelin sheath are tightly regulated by a network of signaling pathways and transcription factors. In the central nervous system, oligodendrocyte differentiation and myelination are controlled by transcription factors such as Olig1, Olig2, and Sox10, which coordinate the expression of myelin genes. Axonal signals, including neuregulin-1, regulate Schwann cell myelination in the periphery. Additionally, metabolic pathways such as mTOR signaling are involved in myelin sheath growth and maintenance, integrating nutrient and energy status with myelin production. After nerve injury, the myelin sheath undergoes degeneration, and regeneration is regulated by a complex interplay of intrinsic and extrinsic factors, including the activation of repair pathways in Schwann cells.

Multiple sclerosis (MS) is an autoimmune demyelinating disease of the central nervous system characterized by destruction of the myelin sheath, leading to neurological deficits. The myelin sheath is a primary target of autoimmune attack, and its loss impairs saltatory conduction and axonal support. Experimental models such as experimental autoimmune encephalomyelitis (EAE) are used to study MS pathogenesis and potential remyelination therapies.

Charcot-Marie-Tooth disease (CMT) is a group of inherited peripheral neuropathies caused by mutations in genes encoding myelin proteins, such as PMP22, MPZ, and GJB1. These mutations lead to abnormal myelin sheath structure and function, resulting in muscle weakness and sensory loss. Peripheral nerve injury also causes myelin sheath degeneration, and regeneration is often incomplete, leading to chronic pain and disability.

After peripheral nerve injury, myelin sheaths degenerate and are subsequently regenerated by Schwann cells. This process is critical for functional recovery, and understanding the mechanisms of myelin sheath regeneration can inform therapeutic strategies. Biomaterials such as immunohydrogels have been developed to reconstruct the myelin sheath and promote nerve regeneration.

Mass spectrometry-based proteomics has been used to comprehensively catalogue the protein composition of the myelin sheath, identifying hundreds of proteins including MBP, PLP, and MAG. This approach reveals the molecular anatomy of myelin and can identify disease-associated changes in protein abundance.

Electron microscopy and immunofluorescence are standard methods to visualize myelin sheath ultrastructure and protein localization. These techniques can assess myelin thickness, compaction, and integrity in normal and pathological conditions.

Knockout, knock-in, and transgenic mouse models are widely used to study the function of myelin genes in vivo. For example, MBP knockout mice exhibit severe dysmyelination, demonstrating the essential role of MBP in myelin compaction.

Genome-wide CRISPR knockout screens in oligodendrocyte precursor cells can identify novel genes that regulate myelination. This unbiased approach accelerates the discovery of myelin sheath regulatory networks.

Researchers studying myelin sheath-related genes often need to determine whether a candidate gene is causally involved in myelin formation, maintenance, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and library screening.

The myelin sheath (GO:0043209) is a specialized cellular component essential for nervous system function, enabling rapid signal conduction and providing metabolic support to axons. Its molecular composition and assembly are complex, involving numerous proteins and regulatory pathways. Dysfunction of the myelin sheath underlies devastating neurological diseases, making it a critical research focus. CRISPR-based gene editing offers powerful approaches to study myelin genes and develop therapeutic strategies. EDITGENE provides comprehensive services to support myelin sheath research, from knockout models to library screening.